SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on massive volume as investors bet on the companys role in critical AI infrastructure and its potential as a key player in the optical interconnect market. The community is actively discussing the stock's significant momentum, speculation regarding potential hyperscaler partnerships, and the intense pressure on short sellers amid a tightening pool of available shares.

Dumb SEND IT

Dumb SEND IT ($DSIT) is gaining traction as a high-volatility meme coin, with the community actively rallying around the developer's commitment to avoiding rug pulls through transparent token burns and manual airdrops. Investors are currently hyper-focused on the project's growth potential and upcoming charting developments, urging others to buy and hold as they aim to hit key market cap milestones.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors aggressively rotate into semiconductor stocks following strong sector-wide sentiment, with the community actively debating whether the current momentum is a sustainable long-term re-rating or an overextended bubble primed for a pullback ahead of earnings. While many investors are expressing high conviction in the CPU-to-GPU shift and the company's long-term growth narrative, bears are citing extreme technical indicators and elevated valuations as catalysts for potential near-term volatility.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently trending as investors re-rate the stock as a key AI infrastructure and data center connectivity play following a significant earnings beat and bullish guidance. While community sentiment is divided between those betting on long-term momentum and skeptics who view the stock as overbought and vulnerable to a correction, many are actively tracking its role as a strategic partner to major tech players.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is currently a focus for investors as they navigate complex community debates regarding potential strategic partnerships, the impact of federal steel tariffs, and persistent concerns over debt levels. Community discussions are heavily centered on whether the company's vertically integrated domestic infrastructure will drive a long-term turnaround or if ongoing market manipulation and management decisions will continue to weigh on performance.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is experiencing a significant surge driven by the FDA’s decision to lift clinical holds on key gene-editing programs, which has triggered heavy buying pressure against a massive short interest. Investors are currently focused on the upcoming Phase 3 readout for HAE, viewing the company’s in vivo CRISPR technology as a potential game-changer that could redefine the biotech sector.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors brace for a critical earnings week, with the community closely analyzing the impact of AI capital expenditures on future growth and forward guidance. While some traders express skepticism regarding the company's AI strategy and recent leadership transition, others remain focused on the stability of its services ecosystem and potential momentum ahead of the upcoming earnings report.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing heightened market attention and increased trading volume, with community members actively discussing potential supply-reduction burns and speculative hopes for a project revival. Despite polarized sentiment between those who view it as a high-risk long play and those dismissing it as a legacy project, proponents remain focused on decentralization efforts and prospective chain developments.

Magnachip Semiconductor Corp. engages in the design and manufacture of analog and mixed-signal platform solutions for communications, Internet of Things (IoT), consumer, computing, industrial, and automotive applications. Its products include MOSFETs, IGBTs, AC-DC/DC-DC converters, light-emitting diode (LED) drivers, regulators, power management integrated circuits (PMICs), and industrial applications such as power suppliers, e-bikes, photovoltaic inverters, LED lighting, and motor drives. The company was founded on November 26, 2003 and is headquartered in Cheongju-si, South Korea.

MagnaChip Semiconductor Corp

MagnaChip Semiconductor is currently a focal point for investors due to intensifying speculation regarding a potential buyout or strategic sale, with the community closely tracking rumors involving key South Korean players like LX Semicon. Sentiment is further bolstered by the company's aggressive stock repurchase program, significant cash position, and a pivot toward high-growth sectors like automotive power solutions and OLED technology.

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Compass Therapeutics Inc

Compass Therapeutics is seeing significant investor attention ahead of a pivotal clinical data readout for its Phase 2/3 trial of tovecimig in biliary tract cancer. The community is focused on the potential for strong secondary endpoint results, with many traders closely monitoring the setup as a high-volatility binary event.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ELPW Shorts haven&#39;t covered yet. Will they get more aggressive or time to give up?

StockTwits Web

Elong Power Holding Limited

 Shorts haven't covered yet. Will they get more aggressive or time to give up?